Michael D Henry - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael D Henry

Showing results (41-50 of 75) with videos related to

Pageof 8

Sort By:

Molecular Cancer|July 30, 2015

Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinomaMichael R Miller, Deqin Ma, James Schappet, et al.

Journal of Clinical and Translational Science|May 19, 2025

Building and implementation of a common infrastructure for specimen and data storage at an academic medical centerDonna A Santillan, Laura S Jacobus, Michael D Henry, et al.

Disease Models & Mechanisms|August 6, 2024

The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotypeMary E Herndon, Mitchell Ayers, Katherine N Gibson-Corley, et al.

FEBS Letters|August 16, 2005

Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan functionMotoi Kanagawa, Daniel E Michele, Jakob S Satz, et al.

The American Journal of Pathology|December 3, 2014

Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesisGrant N Burcham, Gregory M Cresswell, Paul W Snyder, et al.

Cancer Research|September 30, 2016

α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo PathwayAfshin Varzavand, Will Hacker, Deqin Ma, et al.

Frontiers in Oncology|November 1, 2023

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibitionMarion Vanneste, Anita Venzke, Soumitra Guin, et al.

The Journal of Biological Chemistry|February 27, 2009

Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGEDaniel Beltrán-Valero de Bernabé, Kei-Ichiro Inamori, Takako Yoshida-Moriguchi, et al.

Frontiers in Oncology|September 25, 2023

Abl kinases can function as suppressors of tumor progression and metastasisMelissa A Marchal, Devon L Moose, Afshin Varzavand, et al.

Molecular Cancer Research : MCR|September 5, 2013

Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinomaBo Zhou, Katherine N Gibson-Corley, Mary E Herndon, et al.

Pageof 8

Search research articles

Showing results (41-50 of 75) with videos related to

Sort By:

Pageof 8

Molecular Cancer|July 30, 2015

Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinomaMichael R Miller, Deqin Ma, James Schappet, et al.

Journal of Clinical and Translational Science|May 19, 2025

Building and implementation of a common infrastructure for specimen and data storage at an academic medical centerDonna A Santillan, Laura S Jacobus, Michael D Henry, et al.

Disease Models & Mechanisms|August 6, 2024

The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotypeMary E Herndon, Mitchell Ayers, Katherine N Gibson-Corley, et al.

FEBS Letters|August 16, 2005

Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan functionMotoi Kanagawa, Daniel E Michele, Jakob S Satz, et al.

The American Journal of Pathology|December 3, 2014

Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesisGrant N Burcham, Gregory M Cresswell, Paul W Snyder, et al.

Cancer Research|September 30, 2016

α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo PathwayAfshin Varzavand, Will Hacker, Deqin Ma, et al.

Frontiers in Oncology|November 1, 2023

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibitionMarion Vanneste, Anita Venzke, Soumitra Guin, et al.

The Journal of Biological Chemistry|February 27, 2009

Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGEDaniel Beltrán-Valero de Bernabé, Kei-Ichiro Inamori, Takako Yoshida-Moriguchi, et al.

Frontiers in Oncology|September 25, 2023

Abl kinases can function as suppressors of tumor progression and metastasisMelissa A Marchal, Devon L Moose, Afshin Varzavand, et al.

Molecular Cancer Research : MCR|September 5, 2013

Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinomaBo Zhou, Katherine N Gibson-Corley, Mary E Herndon, et al.

Pageof 8